Fingernail onychomycosis: One 250 mg tablet once daily for 6 weeks.
Toenail onychomycosis: One 250 mg tablet once daily for 12 weeks.
The optimal clinical effect is seen some months after mycological cure and
cessation of treatment. This is related to the period required for outgrowth of
[CRCL>50]: No changes.
[<50 ]: Manufacturer: Due to lack of data, terbinafine is not
recommended in patients with CRCL <50. NO SPECIFIC RECOMMENDATIONS IN
CURRENT PACKAGE INSERT.
In patients with renal impairment (creatinine clearance <50 mL/min) or
hepatic cirrhosis, the clearance of terbinafine is decreased by
approximately 50% compared to normal volunteers.
See comments above.
National Institutes of Health, U.S. National Library of Medicine,
DailyMed Database. Provides access to the latest drug monographs submitted to the
Food and Drug Administration (FDA). Please review the latest applicable package insert for
additional information and possible updates. A local search
option of this data can be found here.
The authors make no claims of the accuracy of the information contained herein; and these suggested doses are not a substitute for clinical
judgment. Neither GlobalRPh Inc. nor any other party involved in the
preparation of this program shall be liable for any special, consequential, or exemplary damages resulting in whole or part from any user's use of or reliance upon this material.PLEASE READ THE DISCLAIMER
BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU
AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER. Read